Vaccination across the life course is a fundamental pillar for resilient health systems and healthy aging. Despite this, adult vaccination remains one of the most underutilised public health tools across Europe. While all EU Member States run National Immunisation Programmes (NIPs), a lack of consistent targets, strategies, and dedicated funding has resulted in significant gaps in coverage, access, and overall public health impact. This disparity is starkly visible in influenza vaccine uptake among older adults, which ranges from as low as 10% to nearly 80% across the continent.
The CLCI proposes a realistic and politically feasible approach to enhance adult vaccination through nationally led solutions, bolstered by EU-set goals and coordination. The core of this strategy involves shifting the focus from fragmented national efforts to a shared, measurable vision. This includes agreeing on ambitious yet achievable objectives, such as:
-
Setting EU-determined goals, like aiming for over 90% coverage of influenza and Tdap (Tetanus, diphtheria, and acellular pertussis) in older adults.
-
Strengthening surveillance systems through EU investment in interoperable, real-time data.
-
Developing comprehensive adult vaccine registries in every Member State to track uptake and enable cross-border verification.
-
Securing sustainable financing by reimbursing vaccination on par with curative services and expanding delivery through community providers.
-
Building public trust and countering misinformation through communication campaigns co-designed with civil society.
Read the full policy brief to explore the detailed recommendations for action and the current European landscape of adult immunisation.
OTHER REPORTS
Winter Respiratory Viruses in Europe
Each winter, Europe faces a predictable but preventable surge of respiratory viruses, including influenza, COVID-19, RSV, pneumococcal disease, and hMPV. Older adults and those with chronic health conditions remain the most at risk, with seasonal waves placing...
Launch of the MEP Interest Group on Life Course Immunisation
The MEP Interest Group on Life Course Immunisation (LCI) officially launched on 30 January 2025 at the European Parliament. Established to champion lifelong immunisation policies across Europe, the group aims to position vaccination as a fundamental component of...
Meeting Report on Preventing Mosquito-Borne Diseases: Preparing for Responsible Travel in Europe
This report sheds light on the growing risks of diseases like dengue, chikungunya, and Zika spreading in Europe, driven by climate change and increasing travel. Warmer temperatures are creating the perfect conditions for mosquitoes to thrive, turning diseases once...
JOIN US
Contribute to global public health policy and protect population health.
Stride forward with us to prevent disease through widespread immunisation. Together, we can redefine health landscapes and contribute to a world where everyone, regardless of age, can be protected from vaccine-preventable diseases.
GET IN TOUCH
For general enquires, email:
secretariat@cl-ci.org
For research requests and opportunities, email:
research@cl-ci.org